Atlas Trials

Paxlovid in the Treatment of COVID-19 Patients With Uremia

Clinical trial NCT05386433 · UNKNOWN

Trial details

NCT number
NCT05386433
Sponsor
Ruijin Hospital
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
COVID-19Uremia
Start date
2022-06-01
Primary completion
2022-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.